Cell and Gene Therapy Clinical Trials- Laboratory Solutions
Cell and gene therapy (CGT) is a method that uses gene therapy vectors to transduce exogenous therapeutic genes into cells, and then changes the original gene expression of cells through the transcription and translation of exogenous genes to treat diseases.Gene therapy starts from the root of protein synthesis -- DNA, and changes the transmission of genetic information by regulating DNA, so as to change the properties of proteins and achieve the treatment of diseases from the root.With many years of experience in clinical sample detection and multi-platform collaborative overall solutions, our team has a deep understanding of various diseases and can provide solutions for various indications and various types of cell and gene therapy.
Pharmacokinetics (PK) Study
Servies: CAR-T Cell Count, CAR Copy Analysis, Nucleic Acid, Carrier Detection, etc.
Platforms: Flow, LBA, PCR, etc.
Samples: Blood, Urine, Pleural Effusion, Ascites, etc.
Pharmacodynamics (PD) Study
Servies: PD Markers, etc.
Platforms: LBA, NGS, Flow, PCR, Elispot, IHC, etc.
Samples: Blood, Urine, Cerebrospinal Fluid, Thoracoabdominal Tluid, Tissue, etc.
Safety Testing
Servies: Cytokines and Inflammatory Factors, lentivirus Replication Ability, Immunogenicity, Sterility Identification, Mycoplasma Identification, etc.
Platforms: LBA, Flow, PCR, etc.
Samples: Blood, Urine, Cerebrospinal Fluid, Thoracoabdominal Fluid, etc.
Biomarker Study
Servies: Clinical Endpoint Markers, Exploratory Biomarkers, Tumor Microenvironment, etc.
Platforms: IHC, FISH, PCR, NGS, mIHC, Flow, LBA, Olink, etc.
Samples: Blood, Urine, Cerebrospinal Fluid, Thoracoabdominal Fluid, Tissue, etc.
Companion Diagnostic
Servies: Marker Confirmation and Detection, etc.
Platforms: IHC, PCR, etc.
Samples: Tissue, etc.
